Polymorph of a pharmaceutical

Details for Australian Patent Application No. 2007202956 (hide)

International Classifications

Event Publications

12 July 2007 Complete Application Filed

19 July 2007 Application Open to Public Inspection

Published as AU-B-2007202956

13 December 2007 Section 223 Application Allowed

Abbott Laboratories The time in which to make a further application for a divisional patent has been extended to 15 Jul 2007. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

12 February 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

28 May 2009 Section 223 Application Received

Abbott Laboratories An application to extend the time from 19 Jul 2008 to 19 Feb 2009 in which to pay a continuation fee has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

16 July 2009 Section 223 Application Allowed

Abbott Laboratories The time in which to pay a continuation fee has been extended to 19 Feb 2009. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

12 May 2011 Application Accepted

Published as AU-B-2007202956

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.